{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T17:08:33Z","timestamp":1764781713183},"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Special Issue","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacogenetics"],"published-print":{"date-parts":[[1995,12]]},"DOI":"10.1097\/00008571-199512001-00011","type":"journal-article","created":{"date-parts":[[2006,10,17]],"date-time":"2006-10-17T03:20:56Z","timestamp":1161055256000},"page":"S108-S117","source":"Crossref","is-referenced-by-count":28,"title":["Metabolic polymorphisms and carcinogen-DNA adduct formation in human populations"],"prefix":"10.1097","volume":"5","author":[{"given":"Keith R.","family":"Kaderlik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred F.","family":"Kadlubar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","container-title":["Pharmacogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00008571-199512001-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T01:55:46Z","timestamp":1623808546000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.lww.com\/00008571-199512001-00011"}},"subtitle":[""],"short-title":[],"issued":{"date-parts":[[1995,12]]},"references-count":0,"journal-issue":{"issue":"Special Issue"},"URL":"https:\/\/doi.org\/10.1097\/00008571-199512001-00011","relation":{},"ISSN":["0960-314X"],"issn-type":[{"value":"0960-314X","type":"print"}],"subject":[],"published":{"date-parts":[[1995,12]]}}}